Mary Flora Samuel
About Mary Flora Samuel
Mary Flora Samuel is the Associate Director of Clinical Trial Planning & Execution at Bristol-Myers Squibb in the Greater New York City Area, with over 14 years of experience in clinical trial management across various therapeutic areas.
Company
Mary Flora Samuel is currently employed at Bristol-Myers Squibb, a global biopharmaceutical company known for its commitment to discovering, developing, and delivering innovative medicines to patients with serious diseases. She holds the position of Associate Director, Clinical Trial Planning & Execution in the Greater New York City Area.
Title
As the Associate Director, Clinical Trial Planning & Execution at Bristol-Myers Squibb, Mary Flora Samuel oversees the strategic planning and execution of clinical trials. Her role includes orchestrating data-driven country feasibility studies and managing site and patient allocations to ensure the smooth facilitation of clinical trials across various therapeutic areas.
Education and Expertise
Mary Flora Samuel earned her Master of Science in Microbiology from The Institute of Science, Mumbai, and holds a Bachelor of Science in Microbiology and Biochemistry from St. Xavier's College, Mumbai. She leverages over 14 years of experience in clinical research, specializing in areas such as Oncology, Immunology, Fibrosis, Cardiovascular, Immuno-Oncology, Metabolics, and Virology. Her expertise extends to governance, outsourcing, vendor management, and designing and maintaining SharePoint Online content.
Background
Mary Flora Samuel's career in clinical research began at SRL RANBAXY as a Clinical Research Coordinator. She then joined Bristol-Myers Squibb, where she has progressed through a variety of roles including Clinical Trial Associate, Drug Supply Specialist, Clinical Site Monitor, Senior Clinical Site Monitor, Project Manager/Site Manager, Outsourcing Manager, and her current role as Associate Director. Her diverse background encompasses both project management and operational roles, reflecting her comprehensive understanding of clinical trial processes.
Achievements
Throughout her career, Mary Flora Samuel has led global initiatives and provided mentorship and training within the clinical research industry. She is experienced in risk and issue management to monitor portfolio health, and collaborates with analytics teams, operations leads, and country hub managers to enhance clinical trial feasibility. Moreover, she contributes to the development and implementation of data-driven processes and tools designed to optimize clinical trial site selection on a global scale.